Modulation of histone acetyltransferase activity through interaction of epstein-barr nuclear antigen 3C with prothymosin alpha

Molecular and Cellular Biology

Volumn 20, Issue 15, 2000, Pages 5722-5735

  Cotter II, Murray A ^a   Robertson, Erle S ^a,b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPSTEIN BARR VIRUS ANTIGEN; HISTONE ACETYLTRANSFERASE; PROTHYMOSIN ALPHA;

ACETYLATION; ARTICLE; B LYMPHOCYTE; CELL IMMORTALIZATION; CELL TRANSFORMATION; ENZYME ACTIVITY; ENZYME REGULATION; EPSTEIN BARR VIRUS; GENETIC TRANSCRIPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

ACETYLATION; ACETYLTRANSFERASES; B-LYMPHOCYTES; BURKITT LYMPHOMA; CELL LINE, TRANSFORMED; CELL NUCLEUS; DOWN-REGULATION; EPSTEIN-BARR VIRUS NUCLEAR ANTIGENS; HISTONE ACETYLTRANSFERASES; HISTONES; HUMANS; NUCLEAR PROTEINS; PROTEIN PRECURSORS; SACCHAROMYCES CEREVISIAE PROTEINS; THYMOSIN; TRANS-ACTIVATORS; TRANSFECTION; TWO-HYBRID SYSTEM TECHNIQUES;

DNA VIRUSES; HUMAN HERPESVIRUS 4;

EID: 0033942157     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.20.15.5722-5735.2000     Document Type: Article

References (91)

1. Aiyar, A., C. Tyree, and B. Sugden. 1998. The plasmid replicon of EBV consists of multiple cis-acting elements that facilitate DNA synthesis by the cell and a viral maintenance element. EMBO J. 17:6394-6403.
2. Alfieri, C., M. Birkenbach, and E. Kieff. 1991. Early events in Epstein-Barr virus infection of human B lymphocytes. Virology 181:595-608. (Erratum, 185:946.)
3. Ambinder, R. F. 1990. Human lymphotropic viruses associated with lymphoid malignancy: Epstein-Barr and HTLV-1. Hematol. Oncol. Clin. N. Am. 4:821-833.
4. Artavanis-Tsakonas, S., K. Matsuno, and M. E. Fortini. 1995. Notch signaling. Science 268:225-232.
5. Artavanis-Tsakonas, S., M. D. Rand, and R. J. Lake. 1999. Notch signaling: cell fate control and signal integration in development. Science 284:770-776.
6. Aster, J. C., E. S. Robertson, R. P. Hasserjian, J. R. Turner, E. Kieff, and J. Sklar. 1997. Oncogenic forms of NOTCH1 lacking either the primary binding site for RBP-Jκ or nuclear localization sequences retain the ability to associate with RBP-Jκ and activate transcription. J. Biol. Chem. 272:11336-11343.
7. Bain, M., R. J. Watson, P. J. Farrell, and M. J. Allday. 1996. Epstein-Barr virus nuclear antigen 3C is a powerful repressor of transcription when tethered to DNA. J. Virol. 70:2481-2489.
8. Brou, C., F. Logeat, M. Lecourtois, J. Vandekerckhove, P. Kourilsky, F. Schweisguth, and A. Israel. 1994. Inhibition of the DNA-binding activity of Drosophila suppressor of hairless and of its human homolog, KBF2/RBP-J kappa, by direct protein-protein interaction with Drosophila hairless. Genes Dev. 8:2491-2503.
9. Chakravarti, D., V. J. LaMorte, M. C. Nelson, T. Nakajima, I. G. Schulman, H. Juguilon, M. Montminy, and R. M. Evans. 1996. Role of CBP/P300 in nuclear receptor signalling. Nature 383:99-103.
10. Chakravarti, D., V. Ogryzko, H. Y. Kao, A. Nash, H. Chen, Y. Nakatani, and R. M. Evans. 1999. A viral mechanism for inhibition of p300 and PCAF acetyltransferase activity. Cell 96:393-403.
11. Cohen, J. I., F. Wang, J. Mannick, and E. Kieff. 1989. Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation. Proc. Natl. Acad. Sci. USA 86:9558-9562.
12. Diaz-Jullien, C., A. Perez-Estevez, G. Covelo, and M. Freire. 1996. Prothymosin alpha binds histones in vitro and shows activity in nucleosome assembly assay. Biochim. Biophys. Acta 1296:219-227.
13. Dominguez, F., C. Magdalena, E. Cancio, E. Roson, J. Paredes, L. Loidi, J. Zalvide, M. Fraga, J. Forteza, B. J. Regueiro, et al. 1993. Tissue concentrations of prothymosin alpha: a novel proliferation index of primary breast cancer. Eur. J. Cancer 6:893-897.
14. Eckner, R., M. E. Ewen, D. Newsome, M. Gerdes, J. A. DeCaprio, J. B. Lawrence, and D. M. Livingston. 1994. Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor. Genes Dev. 8:869-884.
15. Eilers, M., S. Schirm, and J. M. Bishop. 1991. The MYC protein activates transcription of the alpha-prothymosin gene. EMBO J. 10:133-141.
16. Eschenfeldt, W. H., and S. L. Berger. 1986. The human prothymosin alpha gene is polymorphic and induced upon growth stimulation: evidence using a cloned cDNA. Proc. Natl. Acad. Sci. USA 83:9403-9407.
17. Felzien, L. K., S. Farrell, J. C. Betts, R. Mosavin, and G. J. Nabel. 1999. Specificity of cyclin E-Cdk2, TFIIB, and E1A interactions with a common domain of the p300 coactivator. Mol. Cell. Biol. 19:4241-4246.
18. Felzien, L. K., C. Woffendin, M. O. Hottiger, R. A. Subbramanian, E. A. Cohen, and G. J. Nabel. 1998. HIV transcriptional activation by the accessory protein, VPR, is mediated by the p300 co-activator. Proc. Natl. Acad. Sci. USA 95:5281-5286.
19. Frangou-Lazaridis, M., M. Clinton, G. J. Goodall, and B. L. Horecker. 1988. Prothymosin alpha and parathymosin: amino acid sequences deduced from the cloned rat spleen cDNAs. Arch. Biochem. Biophys. 263:305-310.
20. Gahn, T. A., and B. Sugden. 1995. An EBNA-1-dependent enhancer acts from a distance of 10 kilobase pairs to increase expression of the Epstein-Barr virus LMP gene. J. Virol. 69:2633-2636.
21. Gast, K., H. Damaschun, K. Eckert, K. Schulze-Forster, H. R. Maurer, M. Muller-Frohne, D. Zirwer, J. Czarnecki, and G. Damaschun. 1995. Prothymosin alpha: a biologically active protein with random coil conformation. Biochemistry 34:13211-13218.
22. Giles, R. H., D. J. M. Peters, and M. H. Breuning. 1998. Conjunction dysfunction: CBP/p300 in human disease. Trends Genet. 14:178-183.
23. Gomez-Marqnez, J., and P. Rodriguez. 1998. Prothymosin alpha is a chromatin-remodelling protein in mammalian cells. Biochem. J. 333:1-3.
24. Gomez-Marquez, J., and F. Segade. 1988. Prothymosin alpha is a nuclear protein. FEBS Lett. 226:217-219.
25. Gomez-Marquez, J., F. Segade, M. Dosil, J. G. Pichel, X. R. Bustelo, and M. Freire. 1989. The expression of prothymosin alpha gene in T lymphocytes and leukemic lymphoid cells is tied to lymphocyte proliferation. J. Biol. Chem. 264:8451-8454.
26. Goodall, G. J., F. Dominguez, and B. L. Horecker. 1986. Molecular cloning of cDNA for human prothymosin alpha. Proc. Natl. Acad. Sci. USA 83:8926-8928.
27. Graziano, V., S. E. Gerchman, D. K. Schneider, and V. Ramakrishnan. 1994. Histone H1 is located in the interior of the chromatin 30-nm filament. Nature 368:351-354.
28. Hamamori, Y., V. Sartorelli, V. Ogryzko, P. L. Puri, H. Y. Wu, J. Y. Wang, Y. Nakatani, and L. Kedes. 1999. Regulation of histone acetyltransferases p300 and PCAF by the bHLH protein twist and adenoviral oncoprotein E1A. Cell 96:405-413.
29. Hammerschmidt, W., and B. Sugden. 1989. Genetic analysis of immortalizing functions of Epstein-Barr virus in human B lymphocytes. Nature 340: 393-397.
30. Harper, J. W., G. R. Adami, N. Wei, K. Keyomarsi, and S. J. Elledge. 1993. The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases. Cell 75:805-816.
31. Harper, J. W., S. J. Elledge, K. Keyomarsi, B. Dynlacht, L. H. Tsai, P. Zhang, S. Dobrowolski, C. Bai, L. Connell-Crowley, E. Swindell, et al. 1995. Inhibition of cyclin-dependent kinases by p21. Mol. Biol. Cell 6:387-400.
32. Hartzog, G. A., and F. Winston. 1997. Nucleosomes and transcription: recent lessons from genetics. Curr. Opin. Genet. Dev. 7:192-198.
33. Hitt, M. M., M. J. Allday, T. Hara, L. Karran, M. D. Jones, P. Busson, T. Tursz, I. Ernberg, and B. E. Griffin. 1989. EBV gene expression in an NPC-related tumour. EMBO J. 8:2639-2651.
34. Hsieh, J. J., T. Henkel, P. Salmon, E. Robey, M. G. Peterson, and S. D. Hayward. 1996. Truncated mammalian Notch1 activates CBF1/RBPJk-repressed genes by a mechanism resembling that of Epstein-Barr virus EBNA2. Mol. Cell. Biol. 16:952-959.
35. Imhof, A., X. J. Yang, V. V. Ogryzko, Y. Nakatani, A. P. Wolffe, and H. Ge. 1997. Acetylation of general transcription factors by histone acetyltransferases. Curr. Biol. 7:689-692.
36. Johannsen, E., C. L. Miller, S. R. Grossman, and E. Kieff. 1996. EBNA-2 and EBNA-3C extensively and mutually exclusively associate with RBPJκ in Epstein-Barr virus-transformed B lymphocytes. J. Virol. 70:4179-4183.
37. Kamei, Y., L. Xu, T. Heinzel, J. Torchia, R. Kurokawa, B. Gloss, S. C. Lin, R. A. Heyman, D. W. Rose, C. K. Glass, and M. G. Rosenfeld. 1996. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors. Cell 85:403-414.
38. Kao, H. Y., P. Ordentlich, N. Koyano-Nakagawa, Z. Tang, M. Downes, C. R. Kintner, R. M. Evans, and T. Kadesch. 1998. A histone deacetylase corepressor complex regulates the Notch signal transduction pathway. Genes Dev. 12:2269-2277.
39. Karetsou, Z., R. Sandaltzopoulos, M. Frangou-Lazaridis, C. Y. Lai, O. Tsolas, P. B. Becker, and T. Papamarcaki. 1998. Prothymosin alpha modulates the interaction of histone H1 with chromatin. Nucleic Acids Res. 26:3111-3118.
40. Kaye, K. M., K. M. Izumi, and E. Kieff. 1993. Epstein-Barr virus latent membrane protein 1 is essential for B-lymphocyte growth transformation. Proc. Natl. Acad. Sci. USA 90:9150-9154.
41. Kieff, E. 1996. Epstein-Barr virus and its replication, 3rd ed., vol. 2. Lippincott-Raven, Philadelphia, Pa.
42. Kirchmaier, A. L., and B. Sugden. 1997. Dominant-negative inhibitors of EBNA-1 of Epstein-Barr virus. J. Virol. 71:1766-1775.
43. Kouzarides, T. 1999. Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9:40-48.
44. Le Roux, A., B. Kerdiles, D. Walls, J. F. Dedieu, and M. Perricaudet. 1994. The Epstein-Barr virus determined nuclear antigens EBNA-3A, -3B, and -3C repress EBNA-2-mediated transactivation of the viral terminal protein 1 gene promoter. Virology 205:596-602.
45. Ling, P. D., D. R. Rawlins, and S. D. Hayward. 1993. The Epstein-Barr virus immortalizing protein EBNA-2 is targeted to DNA by a cellular enhancerbinding protein. Proc. Natl. Acad. Sci. USA 90:9237-9241.
46. Loidi, L., A. Vidal, J. B. Zalvide, J. L. Puente, F. Reyes, and F. Dominguez. 1997. Development of ELISA to estimate thymosin alpha1, the N terminus of prothymosin alpha, in human tumors. Clin. Chem. 43:59-63.
47. Longnecker, R. 1994. Biochemical and genetic studies of Epstein-Barr virus latent membrane protein 2. Leukemia 8(Suppl. 1):S46-S50.
48. Lundblad, J. R., R. P. Kwok, M. E. Laurance, M. L. Harter, and R. H. Goodman. 1995. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature 374:85-88.
49. Mannick, J. B., J. I. Cohen, M. Birkenbach, A. Marchini, and E. Kieff. 1991. The Epstein-Barr virus nuclear protein encoded by the leader of the EBNA RNAs is important in B-lymphocyte transformation. J. Virol. 65:6826-6837.
50. Manrow, R. E., and S. L. Berger. 1993. GAG triplets as splice acceptors of last resort. An unusual form of alternative splicing in prothymosin alpha pre-mRNA. J. Mol. Biol. 234:281-288.
51. Manrow, R. E., A. R. Sburlati, J. A. Hanover, and S. L. Berger. 1991. Nuclear targeting of prothymosin alpha. J. Biol. Chem. 266:3916-3924.
52. Marchini, A., R. Longnecker, and E. Kieff. 1992. Epstein-Barr virus (EBV)-negative B-lymphoma cell lines for clonal isolation and replication of EBV recombinants. J. Virol. 66:4972-4981.
53. Marshall, D., and C. Sample. 1995. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator. J. Virol. 69:3624-3630.
54. Maunders, M. J., L. Petti, and M. Rowe. 1994. Precipitation of the Epstein-Barr virus protein EBNA 2 by an EBNA 3c-specific monoclonal antibody. J. Gen. Virol. 75:769-787.
55. Moran, E. 1993. DNA tumor virus transforming proteins and the cell cycle. Curr. Opin. Genet. Dev. 3:63-70.
56. Mori, M., G. F. Barnard, R. J. Staniunas, J. M. Jessup, G. D. Steele, Jr., and L. B. Chen. 1993. Prothymosin-alpha mRNA expression correlates with that of c-myc in human colon cancer. Oncogene 8:2821-2826.
57. Mosialos, G., M. Birkenbach, R. Yalamanchili, T. VanArsdale, C. Ware, and E. Kieff. 1995. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 80:389-399.
58. Ogryzko, V. V., R. L. Schlitz, V. Russanova, B. H. Howard, and Y. Nakatani. 1996. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell 87:953-959.
59. Perkins, N. D., L. K. Felzien, J. C. Betts, K. Leung, D. H. Beach, and G. J. Nabel. 1997. Regulation of NF-κB by cyclin-dependent kinases associated with the p300 coactivator. Science 275:523-527.
60. Puri, P. L., V. Sartorelli, X. J. Yang, Y. Hamamori, V. V. Ogryzko, B. H. Howard, L. Kedes, J. Y. Wang, A. Graessmann, Y. Nakatani, and M. Levrero. 1997. Differential roles of p300 and PCAF acetyltransferases in muscle differentiation. Mol. Cell 1:35-45.
61. Raab-Traub, N., and J. Webster-Cyriaque. 1997. Epstein-Barr virus infection and expression in oral lesions. Oral Dis. 3(Suppl. 1):S164-S170.
62. Radkov, S. A., R. Touitou, A. Brehm, M. Rowe, M. West, T. Kouzarides, and M. J. Allday. 1999. Epstein-Barr virus nuclear antigen 3C interacts with histone deacetylase to repress transcription. J. Virol. 73:5688-5697.
63. Rickinson, A., and E. K. 1996. Epstein-Barr virus. 3rd ed., vol. 2. Lippincott-Raven, Philadelphia. Pa.
64. Robertson, E. S. 1997. The Epstein-Barr virus EBNA3 protein family as regulators of transcription. Epstein-Barr Virus Rep. 4:143-150.
65. Robertson, E. S., and E. Kieff. 1995. Genetic analysis of Epstein-Barr virus in B lymphocytes. Epstein-Barr Virus Rep. 2:73-80.
66. Robertson, E. S., S. Grossman, E. Johannsen, C. Miller, J. Lin, B. Tomkinson, and E. Kieff. 1995. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein Jκ. J. Virol. 69:3108-3116.
67. Robertson, E. S., J. Lin, and E. Kieff. 1996. The amino-terminal domains of Epstein-Barr virus nuclear proteins 3A, 3B, and 3C interact with RBPJκ. J. Virol. 70:3068-3074.
68. Rodriguez, P., J. E. Vinuela, L. Alvarez-Fernandez, M. Buceta, A. Vidal, F. Dominguez, and J. Gomez-Marquez. 1998. Overexpression of prothymosin alpha accelerates proliferation and retards differentiation in HL-60 cells. Biochem. J. 331:753-761.
69. Sample, J., L. Young, B. Martin, T. Chatman, E. Kieff, and A. Rickinson. 1990. Epstein-Barr virus types 1 and 2 differ in their EBNA-3A, EBNA-3B. and EBNA-3C genes. J. Virol. 64:4084-4092.
70. Sburlati, A. R., R. E. Manrow, and S. L. Berger. 1990. Human prothymosin alpha: purification of a highly acidic nuclear protein by means of a phenol extraction. Protein Expr. Purif. 1:184-190.
71. Sburlati, A. R., R. E. Manrow, and S. L. Berger. 1991. Prothymosin alpha antisense oligomers inhibit myeloma cell division. Proc. Natl. Acad. Sci. USA 88:253-257.
72. Shikama, N., J. Lyon, and N. LaThangue. 1997. The p300/CBP family: integrating signals with transcription factors and chromatin. Trends Cell Biol. 7:230-235.
73. Sixbey, J. W., J. G. Nedrud, N. Raab-Traub, R. A. Hanes, and J. S. Pagano. 1984. Epstein-Barr virus replication in oropharyngeal epithelial cells. N. Engl. J. Med. 310:1225-1230.
74. Sternglanz, R. 1996. Histone acetylation: a gateway to transcriptional activation. Trends Biochem. Sci. 21:357-358.
75. Struhl, K. 1998. Histone acetylation and transcription regulatory mechanisms. Genes Dev. 12:599-606.
76. Swaminathan, S., B. Tomkinson, and E. Kieff. 1991. Recombinant Epstein-Barr virus with small RNA (EBER) genes deleted transforms lymphocytes and replicates in vitro. Proc. Natl. Acad. Sci. USA 88:1546-1550.
77. Tomkinson, B., and E. Kieff. 1992. Use of second-site homologous recombination to demonstrate that Epstein-Barr virus nuclear protein 3B is not important for lymphocyte infection or growth transformation in vitro. J. Virol. 66:2893-2903.
78. Tomkinson, B., E. Robertson, and E. Kieff. 1993. Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J. Virol. 67:2014-2025.
79. Tsitsiloni, O. E., J. Stiakakis, A. Koutselinis, J. Gogas, C. Markopoulos, P. Yialouris, S. Bekris, D. Panoussopoulos, V. Kiortsis, W. Voelter, et al. 1993. Expression of alpha-thymosins in human tissues in normal and abnormal growth. Proc. Natl. Acad. Sci. USA 90:9504-9507.
80. Vareli, K., M. Frangou-Lazaridis, and O. Tsolas. 1995. Prothymosin alpha mRNA levels vary with c-myc expression during tissue proliferation, viral infection and heat shock. FEBS Lett. 371:337-340.
81. Vareli, K., O. Tsolas, and M. Frangou-Lazaridis. 1996. Regulation of prothymosin alpha during the cell cycle. Eur. J. Biochem. 238:799-806.
82. Wang, F., H. Kikutani, S. F. Tsang, T. Kishimoto, and E. Kieff. 1991. Epstein-Barr virus nuclear protein 2 transactivates a cis-acting CD23 DNA element. J. Virol. 65:4101-4106.
83. Wang, F., S. F. Tsang, M. G. Kurilla, J. I. Cohen, and E. Kieff. 1990. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1. J. Virol. 64:3407-3416.
84. Wang, L., S. R. Grossman, and E. Kieff. 2000. Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc. Natl. Acad. Sci. USA 97:430-435.
85. Weintraub, H. 1984. Histone-H1-dependent chromatin superstructures and the suppression of gene activity. Cell 38:17-27.
86. Wu, C. L., A. L. Shiau, and C. S. Lin. 1997. Prothymosin alpha promotes cell proliferation in NIH3T3 cells. Life Sci. 61:2091-2101.
87. Yalamanchili, R., X. Tong, S. Grossman, E. Johannsen, G. Mosialos, and E. Kieff. 1994. Genetic and biochemical evidence that EBNA 2 interaction with a 63-kDa cellular GTG-binding protein is essential for B lymphocyte growth transformation by EBV. Virology 204:634-641.
88. Yang, X. J., V. V. Ogryzko, J. Nishikawa, B. H. Howard, and Y. Nakatani. 1996. A p300/CBP-associated factor that competes with the adenoviral on coprotein E1A. Nature 382:319-324.
89. Yates, J., N. Warren, D. Reisman, and B. Sugden. 1984. A cis-acting element from the Epstein-Barr viral genome that permits stable replication of recombinant plasmids in latently infected cells. Proc. Natl. Acad. Sci. USA 81:3806-3810.
90. Zhao, B., D. R. Marshall, and C. E. Sample. 1996. A conserved domain of the Epstein-Barr virus nuclear antigens 3A and 3C binds to a discrete domain of Jκ. J. Virol. 70:4228-4236.
91. Zimber-Strobl, U., L. J. Strobl, C. Meitinger, R. Hinrichs, T. Sakai, T. Furukawa, T. Honjo, and G. W. Bornkamm. 1994. Epstein-Barr virus nuclear antigen 2 exerts its transactivating function through interaction with recombination signal binding protein RBP-J kappa, the homologue of Drosophila Suppressor of Hairless. EMBO J. 13:4973-4982.